查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1235981

女性健康全球市场规模调查和预测：按应用（绝经后骨质疏鬆症、激素性不孕症、子宫内膜异位症/肌瘤、避孕、更年期、多囊卵巢综合症）、按年龄、地区分析，2022-2029 年

Global Women's Health Market Size study & Forecast, by Application (Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome ), by Age and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球女性健康市场价值约为 381.1 亿美元，预计在 2022-2029 年预测期内将以超过 4.8% 的健康增长率增长。

女性健康是指用于治疗影响该人群的各种疾病的程序、药物和手术辅助工具。 泌尿科、营养学、肿瘤学、生殖医学、更年期和其他医学专科均涵盖在内。 改善女性的总体健康状况和改善疾病管理是女性健康的两个主要目标。 许多政府正在加紧努力提高公众对妇女健康的认识。 世界卫生组织 (WHO) 和美国食品和药物管理局 (FDA) 等多个组织正在引入新的安全举措以改善女性健康。 此外，女性慢性病发病率的上升、女性老年人口的增加以及女性健康新产品的不断推出是推动市场增长的主要因素。

多年来，女性慢性病指标促进了全球女性健康市场的增长。 例如，澳大利亚统计局估计，到 2021 年，将近一半 (49.0%) 的澳大利亚女性将患有一种或多种慢性病，五分之一 (20.7%) 的女性将患有两种或两种以上。我认为 据国际癌症研究机构预测，亚太地区将在 2020 年报告 101 万例乳腺癌病例，到 2025 年将增加到 111 万例，到 2030 年将增加到 120 万例。 此外，对公共资助的避孕服务和产品的日益未满足的需求，以及新兴经济体医疗基础设施的发展，将为预测期内的市场提供良好的增长前景。 然而，不愿避孕将阻碍整个 2022-2029 年预测期内的市场增长。

女性健康全球市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于品牌产品的主导地位、早期产品批准和商业化、有利的报销政策以及政府监管支持，北美在收入方面占据了市场主导地位。 另一方面，预计亚太地区在预测期内将以最高复合年增长率增长。 由于老龄化和目标人口增长等因素，以及政府加大力度提高女性人口的健康意识，预计这将在预测期内为市场带来有利可图的增长机会。

近期市场趋势

  • 2021 年 5 月 - Probi 与 Tervisetehnoloogiate Arenduskeskus 签署了一项研发协议，以开发基于益生菌乳酸菌株的阴道健康新产品。
  • 2021 年 5 月，合众集团收购了 Axia Women's Health。 此次收购旨在扩大按需辅助服务，改善患者体验、结果和参与度，并扩大我们的地理足迹。

全球市场报告范围

  • 历史数据：2019-2020-2021
  • 估算基准年：2021 年
  • 预测期：2022-2029
  • 报告范围：收入预测、公司排名、竞争格局、增长因素、趋势
  • 按地区划分：北美、欧洲、亚太地区、拉丁美洲、世界其他地区
  • 定制范围：免费报告定制（最多 8 个工作小时）。 按国家、地区和部门划分的范围的添加和更改。

本研究的目的是弄清近年来各个领域和国家的市场规模，并对未来几年的市场规模进行预测。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还结合了利益相关者投资的潜在微观市场机会，以及主要参与者的竞争格局等详细分析。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 2019-2029 年按地区划分的女性保健市场
    • 女性健康市场，按应用分类，2019-2029
    • 2019-2029 年按年龄划分的女性保健市场
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章女性健康全球市场定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第三章全球女性健康市场动态

  • 女性健康市场影响分析 (2019-2029)
    • 市场驱动力
      • 女性慢性病发病率上升
      • 女性老年人口增加
      • 推出促进女性健康进步的新产品
    • 市场挑战
      • 我对避孕有抵抗力
    • 市场机会
      • 对公共资助的避孕服务和产品的需求日益增长且未得到满足
      • 新兴经济体的医疗保健基础设施增长

第四章全球女性健康市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 最佳投资机会
  • 关键成功策略
  • 业内人士的前景
  • 分析师的建议和结论

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球女性健康市场：按应用

  • 市场概况
  • 全球女性健康市场：按应用、按性能 - 潜力分析
  • 女性健康全球市场估计和预测（按应用）2019-2029
  • 女性健康市场，细分分析
    • 绝经后骨质疏鬆症
    • 荷尔蒙不育症
    • 子宫内膜异位症/子宫肌瘤
    • 节育
    • 更年期
    • 多囊卵巢综合症 (PCOS)

第 7 章全球女性健康市场：按年龄分类

  • 市场概况
  • 全球女性健康市场：按年龄、按表现）- 潜力分析
  • 2019-2029 年全球各年龄段女性健康市场的估计和预测
  • 女性健康市场，细分分析
    • 50 岁以上
    • 其他

第 8 章全球女性健康市场：区域分析

  • 女性健康市场、区域市场概况
  • 北美
    • 美国
      • 按应用分类的估计和预测，2019-2029 年
      • 按年龄估算和预测，2019-2029 年
    • 加拿大
  • 欧洲女性健康市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太地区女性保健品市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲女性保健品市场概况
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 世界其他地方

第 9 章衝突信息

  • 顶级市场策略
  • 公司简介
    • Pfizer Inc.
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 产品概览
      • 近期趋势
    • Novartis AG
    • Ferring Pharmaceuticals
    • Apothecus Pharmaceutical
    • Agile Therapeutics Inc.
    • AstraZeneca plc
    • Merck & Co
    • Teva Pharmaceutical Industries
    • LUPIN Limited
    • Eli Lilly and Company

第 10 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查受访者的特征
  • 调查先决条件

Global Women's Health Market is valued approximately USD 38.11 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.8 % over the forecast period 2022-2029. Women's health refers to the procedures, medications, and surgical aids used to treat the various disorders that affect this population. Urology, nutrition, oncology, reproduction, menopause, and other medical specialties are all covered. Enhancing women's general health and improving illness management are the two main objectives of women's health. The efforts of numerous governments to increase public awareness of women's health are intensifying. Several organizations, such as the World Health Organization (WHO) and the US Food and Drug Administration (FDA), are introducing new safety initiatives to improve women's health. Moreover, rise in incidence of chronic health conditions among women and increasing women geriatric population as well as growing introduction of new products for women's health are key factors driving the market growth.

Over the years the indices of chronic diseases in women are contributing towards the growth of the Global Women's Health Market. For instance- as per Australian Bureau of Statics estimates - as of 2021, Almost half of all females in Australia (49.0%) had one or more chronic conditions, with one in five (20.7%) having two or more. Additionally, as per International Agency for Research on Cancer - In Asia Pacific region around 1.01 million cases of breast cancer reported in 2020, and this number is projected to grow to 1.11 million in 2025, and further 1.20 million in 2030. Also, rising unmet need for publicly funded contraceptive services and products as well as growing healthcare infrastructure in developing economies would create lucrative growth prospectus for the market over the projected period. However, reluctance to Use Contraceptives hinders the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Women's Health Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and early approval & commercialization of products, favorable reimbursement policies, supportive government regulations in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing number of government initiatives for increasing health awareness among female population in the region would create lucrative growth opportunities for the market over the projected period.

Major market players included in this report are:

  • Pfizer Inc.
  • Novartis AG
  • Ferring Pharmaceuticals
  • Apothecus Pharmaceutical
  • Agile Therapeutics Inc.
  • AstraZeneca plc
  • Merck & Co
  • Teva Pharmaceutical Industries
  • LUPIN Limited
  • Eli Lilly and Company

Recent Developments in the Market:

  • In May 2021 - Probi collaborated with Tervisetehnoloogiate Arenduskeskus and signed a research and development agreement to develop novel products based on probiotic lactobacilli strains for vaginal health.
  • In May 2021, Partners Group acquired Axia Women's Health. This acquisition is aimed at expanding in-demand ancillary services, improving patient experience, outcomes and engagement, and expanding its geographical footprint.

Global Women's Health Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Application, Age, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application

    Postmenopausal Osteoporosis

    Hormonal Infertility

    Endometriosis & Uterine Fibroids

    Contraceptives

    Menopause

    Polycystic Ovary Syndrome (PCOS)

By Age

  • 50 Years & above
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Women's Health Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Women's Health Market, by Application, 2019-2029 (USD Billion)
    • 1.2.3. Women's Health Market, by Age, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Women's Health Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Women's Health Market Dynamics

  • 3.1. Women's Health Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rise in incidence of chronic health conditions among women
      • 3.1.1.2. Increasing women geriatric population
      • 3.1.1.3. Growing introduction of new products for women's health
    • 3.1.2. Market Challenges
      • 3.1.2.1. Reluctance to Use Contraceptives
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising unmet need for publicly funded contraceptive services and products.
      • 3.1.3.2. Growing healthcare infrastructure in developing economies

Chapter 4. Global Women's Health Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Women's Health Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Women's Health Market by Application, Performance - Potential Analysis
  • 6.3. Global Women's Health Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 6.4. Women's Health Market, Sub Segment Analysis
    • 6.4.1. Postmenopausal Osteoporosis
    • 6.4.2. Hormonal Infertility
    • 6.4.3. Endometriosis & Uterine Fibroids
    • 6.4.4. Contraceptives
    • 6.4.5. Menopause
    • 6.4.6. Polycystic Ovary Syndrome (PCOS)

Chapter 7. Global Women's Health Market, by Age

  • 7.1. Market Snapshot
  • 7.2. Global Women's Health Market by Age, Performance - Potential Analysis
  • 7.3. Global Women's Health Market Estimates & Forecasts by Age 2019-2029 (USD Billion)
  • 7.4. Women's Health Market, Sub Segment Analysis
    • 7.4.1. 50 Years and Above
    • 7.4.2. others

Chapter 8. Global Women's Health Market, Regional Analysis

  • 8.1. Women's Health Market, Regional Market Snapshot
  • 8.2. North America Women's Health Market
    • 8.2.1. U.S. Women's Health Market
      • 8.2.1.1. Application breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Age breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Women's Health Market
  • 8.3. Europe Women's Health Market Snapshot
    • 8.3.1. U.K. Women's Health Market
    • 8.3.2. Germany Women's Health Market
    • 8.3.3. France Women's Health Market
    • 8.3.4. Spain Women's Health Market
    • 8.3.5. Italy Women's Health Market
    • 8.3.6. Rest of Europe Women's Health Market
  • 8.4. Asia-Pacific Women's Health Market Snapshot
    • 8.4.1. China Women's Health Market
    • 8.4.2. India Women's Health Market
    • 8.4.3. Japan Women's Health Market
    • 8.4.4. Australia Women's Health Market
    • 8.4.5. South Korea Women's Health Market
    • 8.4.6. Rest of Asia Pacific Women's Health Market
  • 8.5. Latin America Women's Health Market Snapshot
    • 8.5.1. Brazil Women's Health Market
    • 8.5.2. Mexico Women's Health Market
    • 8.5.3. Rest of Latin America Women's Health Market
  • 8.6. Rest of The World Women's Health Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Pfizer Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Novartis AG
    • 9.2.3. Ferring Pharmaceuticals
    • 9.2.4. Apothecus Pharmaceutical
    • 9.2.5. Agile Therapeutics Inc.
    • 9.2.6. AstraZeneca plc
    • 9.2.7. Merck & Co
    • 9.2.8. Teva Pharmaceutical Industries
    • 9.2.9. LUPIN Limited
    • 9.2.10. Eli Lilly and Company

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Women's Health Market, report scope
  • TABLE 2. Global Women's Health Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Women's Health Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 4. Global Women's Health Market estimates & forecasts by Age 2019-2029 (USD Billion)
  • TABLE 5. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Women's Health Market
  • TABLE 70. List of primary sources, used in the study of global Women's Health Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Women's Health Market, research methodology
  • FIG 2. Global Women's Health Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Women's Health Market, key trends 2021
  • FIG 5. Global Women's Health Market, growth prospects 2022-2029
  • FIG 6. Global Women's Health Market, porters 5 force model
  • FIG 7. Global Women's Health Market, pest analysis
  • FIG 8. Global Women's Health Market, value chain analysis
  • FIG 9. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Women's Health Market, regional snapshot 2019 & 2029
  • FIG 15. North America Women's Health Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Women's Health Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Women's Health Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Women's Health Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Women's Health Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable